z-logo
open-access-imgOpen Access
Vaccine Supply Problems: A Perspective of the Centers for Disease Control and Prevention
Author(s) -
Lance E. Rodewald,
Walter A. Orenstein,
Dean D. Mason,
Stephen L. Cochi
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/499587
Subject(s) - medicine , immunization , economic shortage , scope (computer science) , perspective (graphical) , disease control , public health , disease , pandemic , vaccination , environmental health , covid-19 , virology , immunology , infectious disease (medical specialty) , government (linguistics) , linguistics , philosophy , nursing , pathology , artificial intelligence , antigen , computer science , programming language
Although immunization is one of the great public health achievements, continued success depends on an available supply of the vaccines that are recommended for routine use. Beginning in 2000, the United States experienced vaccine supply disruptions of unprecedented scope and magnitude. Although most of the supply disruptions have been resolved, it appears that a fragile vaccine supply will be part of the immunization environment in the United States for the foreseeable future. Here, we describe the perspective of the Centers for Disease Control and Prevention on the recent supply disruptions and the methods used to manage vaccine shortages. The present article focuses on routine pediatric vaccines, including influenza virus vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom